18th Mar 2010 07:00
Cyprotex PLC
("Cyprotex" or the "Company")
End of bid discussions
The Board of Cyprotex announced on 2 March 2010 that it had received an unsolicited approach regarding a potential offer for the Company. The Board has rejected this approach and discussions are at an end.
This announcement has been made with the agreement of the other party.
For the purposes of the Takeover Code, the Company is no longer in an Offer Period.
|
Enquiries:
Cyprotex PLC |
|
|
||
|
Steve Harris |
016 2552 5100 |
|
||
|
www.cyprotex.com |
|
|||
|
Execution Noble & Company Limited |
|
|
||
|
John Llewellyn-Lloyd |
020 7456 9191 |
|
||
|
Sam Reynolds |
|
|
||
|
|
|
|
||
|
Public Relations |
|
|
||
|
Financial Dynamics |
|
|
||
|
Ben Brewerton |
020 7831 3113 |
|
||
|
Ben Atwell |
|
|
||
|
John Dineen |
|
|
||
|
|
|
|
||
In accordance with Rule 19.11 of the Code, a copy of this announcement will be published on the Company's website: http://www.cyprotex.com/news/
Related Shares:
CRX.L